GPS Wealth Strategies Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$7.02K Sell
34
-3,357
-99% -$671K 0.01% 430
2025
Q3
$608K Buy
3,391
+658
+24% +$112K 0.06% 169
2025
Q2
$441K Buy
2,733
+377
+16% +$60.1K 0.05% 199
2025
Q1
$401K Sell
2,356
-55
-2% -$9.55K 0.05% 206
2024
Q4
$401K Buy
2,411
+300
+14% +$51.3K 0.05% 202
2024
Q3
$363K Sell
2,111
-85
-4% -$14.1K 0.05% 218
2024
Q2
$338K Sell
2,196
-18
-0.8% -$2.7K 0.05% 197
2024
Q1
$340K Buy
2,214
+179
+9% +$27.3K 0.06% 190
2023
Q4
$322K Sell
2,035
-41
-2% -$5.89K 0.06% 192
2023
Q3
$304K Hold
2,076
0.06% 195
2023
Q2
$318K Buy
2,076
+34
+2% +$5.3K 0.06% 192
2023
Q1
$317K Buy
+2,042
New +$321K 0.07% 185
2022
Q4
Sell
-2,104
Closed -$278K 443
2022
Q3
$278K Buy
2,104
+55
+3% +$7.72K 0.07% 170
2022
Q2
$278K Sell
2,049
-50
-2% -$6.89K 0.07% 177
2022
Q1
$313K Buy
2,099
+105
+5% +$15.5K 0.07% 159
2021
Q4
$323K Hold
1,994
0.07% 160
2021
Q3
$331K Buy
1,994
+60
+3% +$10.2K 0.08% 147
2021
Q2
$334K Hold
1,934
0.08% 150
2021
Q1
$310K Sell
1,934
-40
-2% -$6.85K 0.09% 143
2020
Q4
$332K Buy
1,974
+189
+11% +$30.7K 0.12% 121
2020
Q3
$281K Buy
+1,785
New +$292K 0.11% 119

Other funds holding FBT

GPS Wealth Strategies Group's FBT Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 99% in Q4 2025, selling an estimated $671K and leaving 34 shares worth $7.02K. The position accounts for 0.01% of the portfolio, ranked #430.

GPS Wealth Strategies Group first reported a position in FBT in Q3 2020 and has held it in 21 quarters since. The position peaked at $608K in Q3 2025. 279 funds tracked by Wall St. Rank hold FBT as of Q4 2025.

  • GPS Wealth Strategies Group held 34 shares of First Trust NYSE Arca Biotechnology Index Fund worth $7.02K as of Q4 2025.
  • GPS Wealth Strategies Group sold 3,357 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2025, an estimated $671K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #430 holding.
  • GPS Wealth Strategies Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2020 and has held it in 21 quarters since.
  • GPS Wealth Strategies Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $608K in Q3 2025.
  • 279 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.